Cancer Research
Modified T Cells Show Promise Against Childhood Blood Cancers in NCI Trial
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Clinical Trial
Mar 28, 2026 0
Cancer
32 articles in this topic
Cancer Research
Immunotherapy Before Surgery Shows Promise for Advanced Melanoma Treatment
Phase II trial tests checkpoint inhibitors given before surgery to shrink tumors and improve outcomes in stage III-IV melanoma patients.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Oncolytic Virus Therapy Shows Promise Against Advanced Metastatic Cancers
New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.
Clinical Trial
Mar 28, 2026 0
Cancer Research
High-Intensity Exercise During Bladder Cancer Treatment Shows Promise in BRAVE Trial
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
Clinical Trial
Mar 28, 2026 0
Cancer Research
High-Dose Radiation Therapy Study Reveals Immune System Response Patterns in Cancer
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.
Clinical Trial
Mar 28, 2026 2
Cancer Research
Blood Test Using Exosomes Shows Promise for Monitoring Rare Sarcoma Cancers
French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.
Clinical Trial
Mar 28, 2026 2
Cancer Research
Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer
Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.
Clinical Trial
Mar 28, 2026 1
Cancer Research
New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial
Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.
Clinical Trial
Mar 28, 2026 1
Cancer Research
CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial
Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.
Clinical Trial
Mar 28, 2026 1
Cancer Research
Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial
Modified immune cells targeting GD2 protein demonstrated safety in treating aggressive childhood cancers like neuroblastoma and osteosarcoma.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Cancer Trial Tests Novel Immune Booster BAY 2416964 With Pembrolizumab
Researchers tested a new drug combination targeting immune suppression in advanced solid tumors before early termination.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Immunotherapy Combination Shows Promise Against Advanced Sarcoma in Major Trial
Phase II trial tested nivolumab with or without ipilimumab in 164 patients with metastatic sarcoma that couldn't be surgically removed.
Clinical Trial
Mar 28, 2026 0